PHOENIX partner with AstraZeneca for distribution of UK medicines portfolio

We are delighted to announce that from 1st July 2024, PHOENIX will enter a 2 Reduced Wholesale Model agreement for distribution of AstraZeneca’s portfolio of medicines in the UK.

Customers can purchase the following products through PHOENIX from 1st July:

• Arimidex
• Bevespi
• Bricanyl
• Brilique
• Bydureon BCise
• Byetta
• Casodex
• Crestor
• Daxas
• Faslodex
• Forxiga
• Komboglyze
• Lokelma
• Onglyza
• Oxis
• Pulmicort
• Qtern
• Symbicort
• Trixeo
• Xigduo
• Zoladex

For more information, please contact your PSUK Account Manager.